Epigenetics
Introduction
Epigenetics studies stable yet reversible alterations to the genome that affect gene expression without changing the DNA base sequence. These changes help explain tissue- and cell-type specific gene expression patterns.
Environment and life experiences can influence epigenetic marks across the lifespan, potentially altering disease risk, stress response, metabolism, appearance, behavior, and longevity.
Key epigenetic mechanisms discussed: DNA methylation, histone modifications, chromatin remodeling, and microRNA (miRNA).
Epigenetic marks can be meiotically and mitotically heritable, though heritability of some marks is debated.
Epigenetic programming can begin in utero; maternal exposures can affect the offspring via epigenetic changes. There is also evidence suggesting paternal environmental exposures can influence offspring phenotype epigenetically.
miRNA are included here due to their ability to affect epigenetic phenomena and to be affected by epigenetic states; interplay exists in both directions.
Collectively, these mechanisms can link environmental factors with phenotypic outcomes throughout life and may contribute to aging, disease susceptibility, and longevity.
Acknowledgement: Review emphasizes the potential for nutritional epigenetics (dietary components influencing the epigenome) and environment-gene interactions across generations.
DNA methylation
Definition and key players
DNA methylation primarily occurs at the 5-position of cytosine to form 5-methylcytosine (5-mC), catalyzed by DNA methyltransferases (DNMTs).
S-Adenosylmethionine (SAM) donates the methyl group in this reaction; SAM is produced in the one-carbon metabolism pathway.
5-methylcytosine is present in about 4 ext{--}6 ext{ ext%} of cytosines in the human genome, varying by cell type.
Most DNA methylation occurs at CpG dinucleotides; methylation outside CpG context also occurs in human DNA, though less commonly. The genome contains roughly CpG dinucleotides.
CpG islands are dense CpG regions, often located in promoters; methylation of CpG islands in promoters is usually inversely correlated with transcription because methyl-CpG binding proteins recruit other factors that repress transcription.
Functional consequences
Methylation at promoter CpG islands generally represses transcription by blocking transcription factor binding and recruiting repressive complexes via methyl-CpG binding proteins.
Intragenic methylation (within gene bodies) also regulates transcription, though mechanisms are less well defined.
Aberrant DNA methylation patterns (global hypomethylation with site-specific hypermethylation) are linked to aging and cancer risk, and can alter organ function, memory, bone density, and other health aspects.
DNA methylation across the lifespan
Post-fertilization, both oocyte and sperm methylation patterns are erased, followed by de novo reprogramming to lineage-specific methylation patterns. This reprogramming helps reset epigenetic states in the embryo.
X-chromosome inactivation in female embryos occurs during this period, leaving one active X chromosome. Skewed X-inactivation (unequal inactivation of maternal/paternal X) can occur and appears to increase with age, potentially contributing to sex-differences in disease risk.
Aging is associated with global hypomethylation and site-specific hypermethylation; such patterns are also observed in cancer. Age-related methylation changes can correlate with declines in organ function, memory, and bone density; understanding these patterns may help in preventing age-related health problems.
Maintenance and de novo DNA methylation
Maintenance methylation: DNMT1 preserves methylation patterns during DNA replication, copying methylation from the parental strand to the daughter strand.
De novo methylation: DNMT3A and DNMT3B establish new methylation marks on unmodified cytosines or hemimethylated cytosines, important during early development and imprinting in oocytes.
DNMT3A/B may also methylate cytosines in non-CpG contexts in some cells; this area is still under study.
De novo methylation can occur in differentiated somatic cells at a slow rate.
Localization of DNA methylation by DNA sequence
DNA sequence context (cis-acting elements) can influence methylation patterns.
SNPs can be associated with methylation changes in nearby DNA (cis).
Experiments inserting promoter fragments into mouse ESC genomes showed that methylation level depended on the promoter sequence itself and not on genomic location, indicating sequence-intrinsic determinants of methylation.
TF-binding sites can influence maintenance of methylation patterns; mutations in these sites can alter local methylation maintenance.
Ongoing research is needed to quantify the degree to which DNA sequence versus environment shapes methylation and how environmental exposures modify these patterns.
DNA hydroxymethylation
5-hydroxymethylcytosine (5-hmC)
5-hmC is proposed as a sixth base with regulatory roles similar to 5-mC, present in less than 1 ext{ ext%} of cytosines, with tissue distribution varying by region; CNS has relatively high levels.
Embryonic stem cells show high 5-hmC that declines with differentiation.
5-hmC as an intermediate in demethylation
5-hmC is thought to be an intermediate in active demethylation pathways, which include oxidation of 5-mC to 5-hmC and further oxidation to 5-formylcytosine (5-fC) and 5-carboxylcytosine (5-caC), followed by base excision repair to restore unmodified cytosine.
TET enzymes (Tet1/2/3) catalyze the conversion of 5-mC to 5-hmC and further oxidation products; TET activity depends on iron (II), α-ketoglutarate, and oxygen.
Functions of TET enzymes
TET1 is enriched in embryonic stem cells and binding sites are CpG-dense promoters; TET1 may prevent unwanted DNA methylation by blocking DNMT access and can recruit PRC2 to repress transcription at target genes.
TET1 binding correlates with gene-rich regions and promoters/TSSs; TET1 targets are associated with CpG-dense promoter regions.
3.3. Hydroxymethylation as a transcriptional regulator
Hydroxymethylation at promoters or CpG islands is associated with increased transcription, contrasting with promoter methylation that generally represses transcription.
Mechanism may involve the release of methyl-CpG-binding proteins upon conversion to 5-hmC, altering transcriptional status.
The stability and heritability of 5-hmC are not fully understood, but 5-hmC can influence transcription during its presence on DNA.
Histone modifications
Compacting the DNA
DNA (~147 bp) wraps around histone octamers (H2A, H2B, H3, H4) to form nucleosomes, packaging DNA into chromatin.
Histone tails undergo various post-translational modifications (acetylation, methylation, phosphorylation, ubiquitination, ADP-ribosylation, biotinylation).
These modifications create a dynamic chromatin landscape that modulates transcription; unlike DNA methylation, histone marks may be more context-dependent in heritability across cell generations.
Common modifications to histone tails
Acetylation by histone acetyltransferases (HATs) neutralizes lysine charge, reducing interaction with DNA and generally promoting transcription; deacetylation by HDACs represses transcription.
Phosphorylation adds negative charge to serine/threonine/tyrosine residues, modifying chromatin structure and transcriptional outcomes.
Methylation occurs on lysine or arginine residues via histone methyltransferases; methylation can either activate or repress transcription depending on the residue and degree (e.g., H3K4me3 is associated with active transcription).
Methylation does not change histone charge but serves as a recruitment platform for reader proteins (e.g., CHD1 with H3K4me3; ING family with PHD fingers; JMJD2A with Tudor domains).
Readers recruit additional factors that influence transcription and RNA processing (e.g., spliceosome components).
Chromatin remodeling
Mechanisms for chromatin remodeling
Gene transcription is influenced by chromatin compaction levels: euchromatin (open) vs heterochromatin (compact) restricts or enables access for transcription factors and RNA polymerase.
Remodeling can occur via ATP-dependent chromatin remodeling complexes or covalent histone modifications by Polycomb group proteins, leading to stable or dynamic changes in transcription.
ATP-dependent chromatin remodeling
The SWI/SNF complex is a key ATP-dependent remodeler that binds nucleosomes and creates transient DNA loops, moving DNA around the histone core (nucleosome sliding).
This movement shortens the distance between neighboring nucleosomes and can reposition nucleosomes to affect gene accessibility.
There is evidence for histone transfer or partial disassembly during remodeling, which may be contingent on dinucleosomes; mononucleosome systems sometimes yield different results.
The outcome on transcription depends on whether the target gene resides in open or closed chromatin after remodeling.
Polycomb proteins and their function
Polycomb group (PcG) proteins repress transcription through chromatin remodeling by forming multiprotein complexes (Polycomb Repressor Complexes, PRCs).
PRC2 (e.g., EED–EZH2) trimethylates H3K27, fostering PRC1 recruitment; PRC1 can monoubiquitinate H2A at K119, suppressing transcription by inhibiting elongation.
The assembly and composition of PRCs vary by organism, cell type, developmental stage, and disease state, illustrating the complexity of PcG-mediated regulation.
Interaction of ncRNAs and PRC
Non-coding RNAs (ncRNAs) can guide PRCs to target genes. Short ncRNAs transcribed from promoters can form stem-loop structures that interact with PRC2 via SUZ12, contributing to gene silencing.
Large intergenic non-coding RNAs (lincRNAs) bound by PRC2 can regulate silenced genes; inhibition of PRC2-bound lincRNAs alters expression of normally silenced genes.
X-inactivation involves Xist RNA; RepA ncRNA within Xist recruits PRC2 to initiate and spread X-inactivation, though maintenance may involve additional mechanisms.
MicroRNAs
Mechanism of action
miRNAs are ~20–30 nucleotides long and regulate gene expression post-transcriptionally.
They bind target mRNA sequences via seed region nucleotides 2–8 and typically repress translation or promote mRNA degradation, often within the RISC complex.
miRNAs can reside within introns (co-transcribed with host genes) or be transcribed from dedicated genes as pri-miRNA, which is processed to mature miRNA.
A single miRNA can target multiple mRNAs, and a given mRNA can be targeted by several miRNAs.
Influencing miRNA
Environmental factors can alter miRNA expression, linking external exposures to epigenetic regulation.
There is evidence of feedback between miRNA expression and DNA methylation/histone modifications; miRNAs can regulate DNMT3A/3B and PcG genes, and methylation changes can alter miRNA transcription.
Aberrant miRNA expression has been observed in cancers and can be driven by epigenetic changes.
Exogenous plant miRNAs (e.g., from rice) may enter the mammalian system via ingestion and circulation, potentially regulating mammalian mRNA targets (e.g., rice miR168a targeting human LDLRAP1 in the liver), suggesting cross-kingdom regulation and diet-epigenome interactions.
Environmental influences and epigenetics
Nutritional epigenetics
Dietary components can influence gene expression through DNA methylation and histone modifications, suggesting a potential for an “epigenetic diet.”
One-carbon metabolism controls SAM availability; nutrients involved include vitamins B6, B12, folate, betaine, choline, and amino acids methionine, cysteine, serine, glycine. Deficiencies can alter DNA methylation and histone modifications.
Bioactive nutrients with epigenetic effects include:
EGCG (green tea) inhibits DNMT, reducing global DNA methylation and reactivating silenced tumor suppressor genes such as p16, MGMT, and RECK; it can also upregulate miR-210 (possible anti-cancer effects).
Selenium can influence DNMT1 expression; low selenium reduces global methylation in certain tissues.
Lycopene may have demethylating effects in some breast cancer models, though results require further validation.
Sulforaphane (broccoli sprouts) inhibits HDAC activity; other compounds of interest include butyrate, resveratrol, genistein, curcumin.
The field suggests the possibility of early disease intervention or prevention through diet by modulating the epigenome; however, mechanisms are complex and context-dependent.
Maternal diet
Maternal B-vitamin status can influence offspring cancer risk and imprinting patterns (e.g., Igf2 imprinting linked to colorectal cancer risk in rodents and humans).
Periconceptional folic acid supplementation increases methylation of Igf2 in offspring, potentially affecting cancer risk.
Maternal choline intake influences histone modifications (increases in H3K9me2 and H3K27me3 in fetal tissue), likely via upregulation of histone methyltransferases.
Protein restriction during pregnancy can epigenetically program offspring metabolism (e.g., altered PPARα and glucocorticoid receptor gene expression due to changes in one-carbon metabolism).
In pigs, maternal protein diets affect global DNA methylation in offspring with changes in DNMT1, DNMT2, and DNMT3 expression in liver and skeletal muscle.
Early life experiences
Childhood environment can shape brain epigenetics and stress responses later in life. Example: increased methylation of NR3C1 (neuron-specific glucocorticoid receptor) promoter observed in suicide victims with a history of childhood abuse; parallels in rodent models with maternal care differences (licking/grooming and arched-back nursing) showing altered HPA responses and NR3C1 regulation.
Social stress in mice (social defeat) leads to long-term depressive-like phenotypes and altered hippocampal BDNF expression with increased histone methylation at BDNF promoter regions.
Paternal exposure to social defeat can transmit behavioral effects to offspring, suggesting epigenetic inheritance of stress responses.
Epigenetics and aging
Aging is associated with a general decline in DNA methylation (global hypomethylation) and selective promoter hypermethylation in specific genes, paralleling patterns seen in cancer.
Histone modifications change with age: decreased repressive H3K27me3 in some contexts; increased H4K20 methylation in heterochromatin, signaling altered transcriptional repression and chromatin structure.
These aging-associated epigenetic changes may contribute to age-related diseases or aging itself; targeting these marks could form the basis of interventions to promote healthy aging.
Conclusion and future perspectives
The epigenome comprises multiple modifying systems that regulate gene expression without altering DNA sequence; environment and lifestyle shape these marks across the lifespan and possibly across generations.
Nutritional epigenetics offers potential strategies for disease prevention and health promotion by modulating DNA methylation, histone modifications, and miRNA expression, but requires careful consideration of tissue specificity, timing, and genetic background.
Epigenetic therapies (DNMT and HDAC inhibitors) are already in use for certain cancers; future directions include extending epigenetic interventions to aging and non-cancer diseases, with a need for biomarkers to distinguish healthy epigenetic patterns from disease-associated patterns.
Challenges include tissue- and cell-type specificity of epigenetic marks, inter-individual genetic variation, and the broad environmental complexity humans experience. Cross-species extrapolations require caution.
Timing of interventions matters: prenatal exposure can have different effects than adolescence or adult exposures; thus, window-of-opportunity considerations are central to prevention strategies.
The work highlights ethical and societal considerations around transgenerational epigenetic effects, potential public health implications of nutritional epigenetics, and the need for robust biomarkers and clinical translation.
Key numerical references to remember
Methylation of cytosines (5-mC) occurs in about 4 ext{ ext%} ext{ to } 6 ext{ ext%} of cytosines in the human genome.
The human genome contains roughly CpG dinucleotides.
5-hydroxymethylcytosine accounts for less than 1 ext{ ext%} of cytosines in mammalian DNA, with CNS and embryonic stem cells showing relatively higher levels.
DNA wraps ~ base pairs around a histone octamer in a nucleosome.
miRNAs are typically nucleotides long.
Exogenous plant miRNA (e.g., miR168a from rice) reported to affect mammalian mRNA translation (cross-kingdom regulation) in certain studies, highlighting diet-epigenome interactions.
Foundational concepts reinforced
Epigenetic marks act as a bridge between genome and environment, contributing to phenotypic variability and disease risk without requiring DNA sequence changes.
The interplay between DNA methylation, hydroxymethylation, histone modifications, chromatin remodeling, and ncRNA/miRNA networks creates a complex, integrated regulatory system.
Environmental inputs (nutrition, early life experiences, stress) can reprogram the epigenome with potential lifelong and transgenerational consequences.
Practical implications for exam preparation
Be able to define and distinguish DNA methylation, hydroxymethylation, histone modifications, chromatin remodeling, and miRNA in epigenetic regulation.
Explain how promoter CpG island methylation typically affects transcription and how intragenic methylation may function.
Describe the roles of DNMT1, DNMT3A, and DNMT3B in maintenance versus de novo methylation; mention potential non-CpG methylation context.
Summarize the function of TET enzymes and the proposed roles of 5-hmC in transcriptional regulation and demethylation pathways.
Discuss SWI/SNF remodeling, PRC/PRC2 (Polycomb) function, and how ncRNAs modulate Polycomb activity and X-chromosome inactivation.
Outline the main environmental and nutritional factors that influence the epigenome (one-carbon metabolism, EGCG, selenium, sulforaphane, etc.) and their proposed mechanisms.
Recall key aging-associated epigenetic changes: global hypomethylation with promoter hypermethylation; shifts in H3K27me3 and H4K20me; potential links to aging and cancer.
Example scenarios to consider
A pregnant individual with folate supplementation vs. deficiency: how Igf2 imprinting and methylation could be affected in the offspring and potential downstream cancer risks.
A diet rich in EGCG and sulforaphane modifying DNMT and HDAC activity: potential re-expression of tumor suppressor genes and effects on chromatin state.
Childhood adversity leading to NR3C1 promoter hypermethylation: implications for long-term stress responses and psychiatric risk.
Equations and key relations for quick recall
Methylation reaction (simplified context):
Global hypomethylation with site-specific promoter hypermethylation as an aging/cancer pattern (conceptual).
DNA packaging:
Connections to broader themes
Genomic stability vs plasticity: epigenetic marks balance maintaining genome integrity with allowing adaptive transcriptional changes in response to environment.
Interplay between inheritance and environment: epigenetic marks provide a mechanistic pathway for environment-to-phenotype transmission, including potential transgenerational effects.
Public health and prevention: nutritional quotients (B vitamins, folate, choline, selenium, polyphenols) may have population-wide implications for disease risk via epigenetic modifications.
Ethical and philosophical implications (brief)
Transgenerational epigenetic effects raise questions about responsibility for the health of future generations and the role of maternal/paternal environment, lifestyle, and policy in shaping epigenetic states.
Diet-epigenome interactions suggest potential for personalized nutrition strategies but require rigorous evidence across diverse populations to avoid overgeneralization or misuse.
Interventions targeting the epigenome (e.g., DNMT/HDAC inhibitors) have therapeutic potential beyond cancer, but safety, equity, and long-term effects across tissues and generations warrant careful consideration.
References to key concepts and terms to memorize for exams
5-methylcytosine (5-mC); 5-hydroxymethylcytosine (5-hmC)
DNMT1 (maintenance), DNMT3A/DNMT3B (de novo)
TET enzymes (Tet1/2/3); 5-fC and 5-caC as demethylation intermediates
H3K4me3 (active transcription mark); H3K27me3 (repressive mark via PRC2); H2A K119 ubiquitination (PRC1 effect)
SWI/SNF (ATP-dependent remodeling); Polycomb repressor complexes (PRC1/PRC2)
ncRNAs and lincRNAs in PcG targeting; Xist RepA in X-chromosome inactivation
miRNA seed region (nucleotides 2–8); RISC-mediated silencing; cross-talk with DNMTs and PcG
One-carbon metabolism and SAM as methyl donor; role of B vitamins, folate, choline, betaine, methionine
Nutritional epigenetics: EGCG, sulforaphane, selenium, lycopene, butyrate, resveratrol, genistein, curcumin
Takeaway
Epigenetics provides a mechanistic framework for how environment and diet can influence gene expression and disease risk across the lifespan and potentially across generations, through a network of DNA methylation, hydroxymethylation, histone modifications, chromatin remodeling, and ncRNA/miRNA regulation. Nutritional and life-course factors offer opportunities for intervention, but the complexity of tissue specificity, timing, and genetic context requires careful, evidence-based approaches for translation into health strategies.